...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Watch it before it gets moved to "Off Topic Forum" by the thought police here.

Very much on topic! DM had mentioned one patient that felt Zenith had saved his life so he invested in the company. I wonder if this is he!

Share
New Message
Please login to post a reply